XoNovo is a preclinical-stage biopharmaceutical company engaged in the development of proprietary small molecules for the treatment of neurodegenerative diseases.
XoNovo Ltd.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Website
Disease Focus
Development Stage
STOCK CODENon Listed
AddressNess ZionaIsrael
Ness Ziona
Israel
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/xonovo-ltd-” connections=”true” suffix=””]